Clinical Trials Logo

Clinical Trial Summary

The purpose of the research is to determine whether a medication called dapagliflozin will improve the heart's function and reduce its enlargement after a heart attack. Participation in this study will involve taking the medication dapagliflozin (or a placebo) once daily for six months, one cardiac magnetic resonance imaging (MRI) test during your initial hospitalization, follow-up phone calls at 1 and 3 months, and one cardiac MRI and clinic visit at six months.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05305911
Study type Interventional
Source Minneapolis Heart Institute Foundation
Contact Sarah Schwager, RN
Phone 612-863-3833
Email sarah.schwager@allina.com
Status Recruiting
Phase Phase 2
Start date August 3, 2022
Completion date April 15, 2024

See also
  Status Clinical Trial Phase
Completed NCT04153006 - Comparison of Fingerstick Versus Venous Sample for Troponin I.
Completed NCT04584645 - A Digital Flu Intervention for People With Cardiovascular Conditions N/A
Completed NCT01467232 - IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing Coronary Artery Bypass Grafting Phase 2
Completed NCT05090618 - The Role of Genetic Factors in the Development of Myocardial Infarction in the Kazakh Population
Active, not recruiting NCT03561051 - The Pre-hospital Evaluation of Sensitive Troponin (PRESTO) Study
Completed NCT04664881 - Home Telemonitoring In Patients After Myocardial Infarction N/A
Completed NCT03826914 - The Effects of the Dietary Supplement CardioFlex Q10 on Reducing Cardiovascular Disease Risk Factors in Adults N/A
Withdrawn NCT04198883 - SINGaporean Program Performed With an eXPANsion Medical Device (SingXpand) Phase 1/Phase 2
Completed NCT03649711 - Chronic Kidney Disease (CKD) Platelet Study Phase 3
Completed NCT03677180 - National Cardiogenic Shock Initiative
Completed NCT05415735 - Stress Management and Resiliency Training Following Acute Myocardial Infarction N/A
Completed NCT02376283 - P3AMI Antiplatelet Trial Phase 4
Completed NCT03654157 - ACS Registry - A Non-interventional Study to Estimate the Rates of Outcomes in ACS Patients in Moscow
Completed NCT03252990 - 18F-fluorocholine PET-MR Imaging of Coronary Plaque Vulnerability
Recruiting NCT06271577 - Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II N/A
Recruiting NCT06280976 - Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP) Phase 4
Completed NCT02581540 - Mersey Acute Coronary Syndrome Rule-Out Using High Sensitive Troponin
Recruiting NCT04904107 - Improving the Accuracy of Referrals of Patients With Chest Pain N/A
Completed NCT02032030 - Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys
Completed NCT01407146 - Acute Coronary Syndrome and Care-Seeking Delay: A Web Based Behavioral Study